Cilostazol Enhances Mobilization of Circulating Endothelial Progenitor Cells and Improves Endothelium-Dependent Function in Patients at High Risk of Cardiovascular Disease.

Chao, Ting-Hsing; Chen, I-Chih; Lee, Cheng-Han; Chen, Ju-Yi; Tsai, Wei-Chuan; Li, Yi-Heng; Tseng, Shih-Ya; Tsai, Liang-Miin; Tseng, Wei-Kung

Chao, Ting-Hsing; Chen, I-Chih; Lee, Cheng-Han; Chen, Ju-Yi; Tsai, Wei-Chuan; Li, Yi-Heng; Tseng, Shih-Ya; Tsai, Liang-Miin; Tseng, Wei-Kung.

Afiliação

Chao TH; Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan chaotinghsing@yahoo.com.tw.
Chen IC; Department of Internal Medicine, Tainan Municipal Hospital, Tainan, Taiwan.
Lee CH; Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan.
Chen JY; Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan.
Tsai WC; Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan.
Li YH; Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan.
Tseng SY; Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan Department of Biological Science, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Tsai LM; Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan.
Tseng WK; Division of Cardiology, Department of Internal Medicine, E-Da University College of Medicine and Hospital, Kaohsiung, Taiwan.

Angiology ; 67(7): 638-46, 2016 08.

Article em En | MEDLINE | ID: mdl-27401788

Assuntos

Doenças Cardiovasculares/sangue; Doenças Cardiovasculares/tratamento farmacológico; Células Progenitoras Endoteliais/efeitos dos fármacos; Endotélio Vascular/efeitos dos fármacos; Neovascularização Fisiológica/efeitos dos fármacos; Tetrazóis/farmacologia; Tetrazóis/uso terapêutico; Idoso; Antígenos CD34/sangue; Movimento Celular/efeitos dos fármacos; Cilostazol; Método Duplo-Cego; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Inibidores da Agregação Plaquetária/farmacologia; Inibidores da Agregação Plaquetária/uso terapêutico; Fatores de Risco; Estatística como Assunto; Triglicerídeos/sangue; Fator A de Crescimento do Endotélio Vascular/sangue; Receptor 2 de Fatores de Crescimento do Endotélio Vascular/sangue

Palavras-chave

cardiovascular disease; cilostazol; endothelial function; endothelial progenitor cells; flow-mediated dilatation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetrazóis / Endotélio Vascular / Doenças Cardiovasculares / Neovascularização Fisiológica / Células Progenitoras Endoteliais Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google